UK Health Security Agency

Company

Also known as: UKHSA

Related News

Phase 3 Trial Launches for mRNA H5N1 Bird Flu Vaccine in UK and US

Apr 29, 2026

A phase 3 trial of an mRNA H5N1 bird flu vaccine is recruiting 4,000 volunteers in the UK and US. The Moderna-sponsored study aims to assess immune responses against emerging strains as the virus continues to evolve in mammals.

Moderna Receives UK and EU Approvals for COVID-19 Vaccines

Feb 27, 2026

Moderna announced UK authorization for its updated Spikevax vaccine targeting the LP.8.1 variant and European Commission marketing authorization for mNEXSPIKE, its third vaccine approved in the EU.